COURSE DESCRIPTION:
Personalized medicine helps doctors learn about a person’s genetic makeup and how their tumor grows.  This tumor board discussion will provide an update in the state of the art treatment of oral, head and neck cancers. In addition, “Hot Topics” in immunotherapy, HPV related cancers, thyroid cancer, and proton therapy will be discussed.

TARGET AUDIENCE:
Medical Oncologists, Radiation Oncologists, Otolaryngologists, Surgeons, Radiologists, Hematologists, Pathologists, Plastic Surgeons and Oral and Maxillofacial Surgeons.

LEARNING OBJECTIVES:
•    Improve clinical decision making, clinical outcomes, and patient experience via a multidisciplinary team approach. Group discussion include prospective patient care management, national treatment guidelines, staging, and options and eligibility for genetic testing, clinical research studies, and supportive care services.
•    Develop a comprehensive treatment plan for head and neck oncology patients leveraging imaging and pathology testing results and meet Commission on Cancer accreditation standards compliance. 
 

FACULTY & DISCLOSURES:

Noah S. Kalman, M.D., MBA
Radiation Oncologist 
Miami Cancer Institute

Geoffrey Young, M.D., Ph.D., FACS, FSSO
Chief – Head and Neck Surgery
Miami Cancer Institute
Vice Chair – Surgery
Florida International University


Gerlem Manso Morin,APRN
Miami Cancer Institute
 

Noah Kalman, M.D., director for this educational activity, has no financial relationships with ineligible companies* to disclose.

Geoffrey Young, M.D., director for this educational activity, has no financial relationships with ineligible companies* to disclose.

Gerlem Manso Morin, interprofessional coordinator of this educational activity has no financial relationships with ineligible companies* to disclose.

DMT Coordinators others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*
 

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

image

American Board of Surgery - Maintenance of Certification (MOC) - Accredited CME - Complex General Surgical Oncology

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Successful completion of this course is submitted to specialty boards through the ACCME's PARS system. 

Session date: 
06/20/2024 - 12:00pm to 1:00pm EDT
Location: 
Miami Cancer Institute
United States
  • 1.00 ABS MOC II
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Occupational Therapy
  • 1.00 Florida Board of Pharmacy

Please login or register for a Baptist Health CME account to take this course.